Digital diary for mental health experiences
Part of Mental health clinical trials.
This study tests an online platform where people with certain mental health conditions can share their experiences and outcomes. It may help improve care by collecting patient feedback.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in France and are between 18 and 65 years old
- You are being treated at one of the 12 participating psychiatric facilities
- You have a diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depression
- You have a valid email address and can read French
- You agree to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is building a research database that combines genetic information and long-term health data to improve personalized treatment for serious mental illness. You may be eligible if you have been diagnosed or treated for depression, bipolar disorder, schizophrenia, or dementia.
This trial tests a new digital tool to help college students in France manage their mental health. It aims to see if the tool can improve well-being and provide support.
This trial tests whether a digital health app (with “virtual agents,” like guided prompts/support) can improve people’s health outcomes. You may help the study by using the app and completing its questionnaires.
This study looks at how people with bipolar disorder or depression process social situations, memory, and thinking. It compares patients, their relatives, and healthy volunteers to better understand these conditions.
This trial tests a smartphone app that helps doctors manage depression in everyday life. It may help improve how care is tracked and adjusted soon after starting antidepressant treatment.
This study tests whether remote monitoring through a smartphone, computer, or tablet can help people with depression who are starting a new antidepressant. It aims to see if this approach improves care and outcomes.
Hear when a new Schizophrenia Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.